Meeting
2021 ASCO Annual Meeting
Phase I trial of acoustic cluster therapy (ACT) with chemotherapy in patients with liver metastases of gastrointestinal origin (ACTIVATE study).
Presenter
Udai Banerji, MD, PhD, DNB, FCRP
The Institute of Cancer Research and The Royal Marsden
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
New Targets and New Technologies (non-IO)
Clinical Trial Registration Number
NCT04021277
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr TPS3145)
DOI
10.1200/JCO.2021.39.15_suppl.TPS3145
Abstract #
TPS3145
Poster Bd #
Online Only
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2023 ASCO Annual Meeting
Safety and early biologic effects of phase 1 PERIO-01 trial of pressure-enabled drug delivery (PEDD) of TLR9 agonist SD-101 and immune checkpoint inhibition (ICI) in uveal melanoma metastatic to the liver (MUM).
Speaker: Kamaneh Montazeri, MD
Videos & Slides
2022 ASCO Gastrointestinal Cancers Symposium
Preliminary results of a phase 1 study of sea-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
Speaker: David Lawrence Bajor, MD
Speaker: Panel Discussion
Videos & Slides
2013 ASCO Annual Meeting
Appropriateness Criteria for the Use of 18F-FDG PET/CT in Clinical Practice
Speaker: George Segall, MD